291 web-programmer-developer-"https:"-"UCL"-"University-of-St"-"https:" positions in Switzerland
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
The IOB PhD and MD-PhD Program on Translational Visual Neurosciences offers a unique opportunity to make breakthrough discoveries in the function or dysfunction of the eye and the visual brain, as
-
research environment and to contribute actively to teaching activities Workplace Workplace We offer Training opportunities Perspectives for career development Support programmes (e.g. mentoring) and networks
-
ETH Zurich | Space and the Gravitational Physics Research group led by Prof. Michele Vallisneri in the Dept. of Physics at ETH Zurich invite applications for a Software Engineer position (for one
-
using emerging non-invasive exhalomics (exhaled breath metabolomics) approach. The research program integrates animal experiments with advanced analytical techniques and bioinformatics to enhance
-
to work with leading experts across Europe to develop solutions for Decentralised Critical Infrastructure Asset Monitoring and Condition Assessment . This position focuses on next-generation distributed
-
, ACHIEVE consortium The primary focus of this role is to serve as the Knowledge and Technology Transfer (KTT) Expert within the ACHIEVE consortium as part of the SWEET funding programme of the Swiss Federal
-
. 10007007; project start 01.10.2025: collaboration partners: J. Löffler, ETH Zürich; K. Klein, Universität Zürich; R. Müller, ETH Zürich, B. Schaller, Universitätsspital Bern) focusing on the development
-
-quantitative methods for decision support for sustainable innovation. Your tasks With the PhD work, we plan to adapt and advance the SSbD framework in the area of green electronics, with a special focus on bio
-
80%-100%, Zurich, fixed-term The National Center of Competence in Research, NCCR Catalysis aims to develop skills, tools, and technologies that facilitate the transition towards a carbon-neutral
-
to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees